{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:29:40Z","timestamp":1760189380907},"reference-count":20,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":429,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1002\/pbc.25120","type":"journal-article","created":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T19:04:50Z","timestamp":1404068690000},"page":"1774-1778","source":"Crossref","is-referenced-by-count":10,"title":["International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations"],"prefix":"10.1002","volume":"61","author":[{"given":"Karim Thomas","family":"Sadak","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology; University of Minnesota Children's Hospital; Minneapolis Minnesota"},{"name":"Masonic Cancer Center; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Fultz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics; The George Washington University School of Public Health and Health Services; Washington District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Mendizabal","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics; The George Washington University School of Public Health and Health Services; Washington District of Columbia"},{"name":"The EMMES Corporation; Rockville Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Reaman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; The George Washington School of Medicine and Health Sciences; Washington District of Columbia"},{"name":"Center for Cancer and Blood Disorders; Children's National Medical Center; Washington District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[{"name":"The Max Foundation; Edmonds Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics; The George Washington University School of Public Health and Health Services; Washington District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,29]]},"reference":[{"key":"10.1002\/pbc.25120-BIB0001|pbc25120-cit-0001","volume-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995","year":"1999"},{"key":"10.1002\/pbc.25120-BIB0002|pbc25120-cit-0002","volume-title":"Cancer facts & figures 2011","author":"American Cancer Society","year":"2011"},{"key":"10.1002\/pbc.25120-BIB0003|pbc25120-cit-0003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/14737140.4.1.85","article-title":"Clinical and epidemiologic burden of chronic myelogenous leukemia","volume":"4","author":"Redaelli","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1002\/pbc.25120-BIB0004|pbc25120-cit-0004","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"The Lancet"},{"key":"10.1002\/pbc.25120-BIB0005|pbc25120-cit-0005","article-title":"Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML experts","author":"Kantarjian","year":"2013","journal-title":"Blood"},{"key":"10.1002\/pbc.25120-BIB0006|pbc25120-cit-0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1744-8603-5-19","article-title":"Benefits of global partnerships to facilitate access to medicines in developing countries: A multi-country analysis of patients and patient outcomes in GIPAP","volume":"5","author":"Kanavos","year":"2009","journal-title":"Global Health"},{"key":"10.1002\/pbc.25120-BIB0007|pbc25120-cit-0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canep.2013.01.002","article-title":"Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries","volume":"37","author":"Mendizabal","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1002\/pbc.25120-BIB0008|pbc25120-cit-0008","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2003-09-3032","article-title":"Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: Results from a Children's Oncology Group phase 1 study","volume":"104","author":"Champagne","year":"2001","journal-title":"Blood"},{"key":"10.1002\/pbc.25120-BIB0009|pbc25120-cit-0009","unstructured":"United Nations, World Macro Regions and Components [Internet] 2009"},{"key":"10.1002\/pbc.25120-BIB0010|pbc25120-cit-0010","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program www.seer.cancer.gov"},{"key":"10.1002\/pbc.25120-BIB0011|pbc25120-cit-0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12185-008-0230-0","article-title":"Chronic myeloid leukemia in Asia","volume":"89","author":"Au","year":"2009","journal-title":"Int 494 J Hematol"},{"key":"10.1002\/pbc.25120-BIB0012|pbc25120-cit-0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.22019","article-title":"Nonadherence to imatinib adversely effects event free survival in chronic phase chronic myeloid leukemia","volume":"86","author":"Ganesan","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1002\/pbc.25120-BIB0013|pbc25120-cit-0013","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","article-title":"Prevalence, determinants, and outcomes 478 of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: The ADAGIO study","volume":"113","author":"Noens","year":"2009","journal-title":"Blood"},{"key":"10.1002\/pbc.25120-BIB0014|pbc25120-cit-0014","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/pbc.24397","article-title":"Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH\/IGF-1 axis","volume":"60","author":"Narayanan","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25120-BIB0015|pbc25120-cit-0015","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25120-BIB0016|pbc25120-cit-0016","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2011-10-380774","article-title":"How I treat childhood CML","volume":"119","author":"Andolina","year":"2012","journal-title":"Blood"},{"key":"10.1002\/pbc.25120-BIB0017|pbc25120-cit-0017","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO.2010.32.7114","article-title":"Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: Results of the French national phase IV trial","volume":"29","author":"Millot","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25120-BIB0018|pbc25120-cit-0018","volume-title":"Global cancer facts & figures","author":"American Cancer Society","year":"2011"},{"key":"10.1002\/pbc.25120-BIB0019|pbc25120-cit-0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2354.2008.00985.x","article-title":"Decreasing the cancer burden in developing countries: Concerns and recommendations","volume":"18","author":"Kachroo","year":"2009","journal-title":"Eur J Cancer Care"},{"key":"10.1002\/pbc.25120-BIB0020|pbc25120-cit-0020","unstructured":"World Health Organization (WHO) 2007a Cancer: Diet and physical activity's impact. Available at http:\/\/www.who.int\/dietphysicalactivity\/publications\/facts\/cancer\/en\/"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25120","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.25120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:23:19Z","timestamp":1625397799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25120"}},"subtitle":["International Patterns of Childhood Chronic Myeloid Leukemia"],"short-title":[],"issued":{"date-parts":[[2014,6,29]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25120","relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,29]]}}}